Healthcare provider profile · identity verified

Philip Ondara, ARNP

Nurse Practitioner · RICHLAND, WA · NPI 1639611957

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	147	33
Trazodone Hcl	Trazodone Hcl	143	36
Buspirone Hcl	Buspirone Hcl	139	31
Quetiapine Fumarate	Quetiapine Fumarate	134	33
Furosemide	Furosemide	130	42
Atorvastatin Calcium	Atorvastatin Calcium	115	32
Amlodipine Besylate	Amlodipine Besylate	99	28
Tramadol Hcl	Tramadol Hcl	87	35
Gabapentin	Gabapentin	85	25
Mupirocin	Mupirocin	83	55
Potassium Chloride	Potassium Chloride	82	24
Losartan Potassium	Losartan Potassium	79	17
Metoprolol Succinate	Metoprolol Succinate	76	19
Mirtazapine	Mirtazapine	76	21
Sertraline Hcl	Sertraline Hcl	73	20
Tamsulosin Hcl	Tamsulosin Hcl	71	15
Donepezil Hcl	Donepezil Hcl	69	23
Levothyroxine Sodium	Levothyroxine Sodium	67	26
Escitalopram Oxalate	Escitalopram Oxalate	66	15
Famotidine	Famotidine	66	16
Eliquis	Apixaban	63	16
Lorazepam	Lorazepam	61	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	59	54
Albuterol Sulfate Hfa	Albuterol Sulfate	58	34
Fluticasone Propionate	Fluticasone Propionate	56	36
Diclofenac Sodium	Diclofenac Sodium	54	30
Memantine Hcl	Memantine Hcl	54	15
Omeprazole	Omeprazole	54	18
Glipizide	Glipizide	53	suppressed
Cephalexin	Cephalexin	52	41
Metformin Hcl	Metformin Hcl	47	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	16
Pantoprazole Sodium	Pantoprazole Sodium	45	13
Carvedilol	Carvedilol	44	11
Ibuprofen	Ibuprofen	43	19
Olanzapine	Olanzapine	38	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	12
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Metformin Hcl Er	Metformin Hcl	33	12
Fluconazole	Fluconazole	32	27
Nystatin	Nystatin	30	20
Simvastatin	Simvastatin	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	19
Prednisone	Prednisone	28	22
Metoprolol Tartrate	Metoprolol Tartrate	27	suppressed
Risperidone	Risperidone	27	11
Montelukast Sodium	Montelukast Sodium	26	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Invokana	Canagliflozin	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	22
Tobramycin	Tobramycin	22	22
Zenpep	Lipase/Protease/Amylase	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Ketoconazole	Ketoconazole	20	13
Farxiga	Dapagliflozin Propanediol	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Azithromycin	Azithromycin	18	14
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	18	14
Lamotrigine	Lamotrigine	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Latanoprost	Latanoprost	16	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Glimepiride	Glimepiride	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Haloperidol	Haloperidol	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error